Skip to content

The influence of the double superposition of inflammation on the clinical outcome of patients with schizophrenia comorbid with novel coronavirus pneumonia (COVID-19)

The influence of the double superposition of inflammation on the clinical outcome of patients with schizophrenia comorbid with novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042862
Enrollment
Unknown
Registered
2021-01-30
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Three groups:No intervention

Sponsors

The Sixth Hospital of Peking University / Institute of mental health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Schizophrenia combined with COVID-19 group (1) According to the diagnostic criteria for schizophrenia in the Tenth Revision of the international classification of diseases (ICD-10), patients with schizophrenia were diagnosed by psychiatrists above the attending physician; (2) Patients diagnosed with New Coronavirus pneumonia according to the New Coronavirus pneumonia treatment plan (trial version 7). (3) Subjects older than 18 years old; (4) The subjects who have been educated for 5 years or more can read and understand Chinese; (5) Subjects using atypical antipsychotics. 2. Control group infected with covid-19 alone (1) Patients diagnosed with New Coronavirus pneumonia according to the New Coronavirus pneumonia treatment plan (trial version 7). (2) Patients older than 18 years old; (3) The patients who have been educated for more than 5 years can read and understand Chinese; (4) Patients who did not use atypical antipsychotics; (5) Age, gender, disease severity, medication and basic disease status were matched with the first group. 3. Simple schizophrenia control group (1) According to the diagnostic criteria for schizophrenia in the Tenth Revision of the international classification of diseases (ICD-10), patients with schizophrenia were diagnosed by psychiatrists above the attending physician; (2) Patients older than 18 years old; (3) The subjects who have been educated for 5 years or more can read and understand Chinese; (4) novel coronavirus subjects were not infected. (5) Subjects using atypical antipsychotics; (6) Age, gender, course of disease and severity of the disease were matched with those of the first group.

Exclusion criteria

Exclusion criteria: 1. Pregnant subjects; 2. Patients participating in clinical trials of other new anti coronavirus drugs.

Design outcomes

Primary

MeasureTime frame
cognitive function;relapse;clinical outcomes;Pulmonary function;

Countries

China

Contacts

Public ContactShi Chuan

The Sixth Hospital of Peking University / Institute of mental health

shichuan@bjmu.edu.cn+86 10 62723737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026